San Diego, CA, United States of America

Wanping Mai

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Wanping Mai

Introduction

Wanping Mai is a prominent inventor based in San Diego, California, recognized for his contributions to the field of pharmaceuticals. With a total of three patents to his name, his work primarily focuses on innovative treatments for cancer, immune disorders, and inflammation.

Latest Patents

Among Wanping Mai's latest inventions is the development of crystalline mesylate Form 1 salt of N-hydroxy 2-{6-[(6-fluoro-quinolin-2-ylmethyl)-amino]-3-aza-bicyclo[3.1.0]hex-3-yl}pyrimidine-5-carboxamide. This groundbreaking patent outlines methods for producing this compound, which is effective in preparing pharmaceutical compositions for treating various health conditions, including cancer and immune system-related disorders.

Career Highlights

Throughout his professional journey, Wanping Mai has made significant strides in the pharmaceutical industry. He has worked with notable companies such as Viracta Subsidiary, Inc. and Kura Oncology, Inc., where he contributed his expertise to the development of cutting-edge therapeutic solutions.

Collaborations

Wanping Mai has collaborated with fellow professionals, including Xiaohu Deng and Robert C. McRae, enhancing the innovative process through teamwork and shared knowledge. These collaborations have proven valuable in refining and advancing their research efforts.

Conclusion

In conclusion, Wanping Mai's impactful inventions and collaborations play an essential role in the ongoing fight against cancer and immune disorders. His commitment to innovation continues to inspire the pharmaceutical industry and highlights the importance of research and development in creating effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…